| Literature DB >> 33709127 |
Matteo Bassetti1,2, Elie Azoulay3,4, Bart-Jan Kullberg5, Markus Ruhnke6, Shmuel Shoham7, Jose Vazquez8, Daniele Roberto Giacobbe1, Thierry Calandra9.
Abstract
The EORTC/MSGERC recently revised and updated the consensus definitions of invasive fungal disease (IFD). These definitions primarily focus on patients with cancer and stem cell or solid-organ transplant patients. They may therefore not be suitable for intensive care unit (ICU) patients. More in detail, while the definition of proven IFD applies to a broad range of hosts, the categories of probable and possible IFD were primarily designed for classical immunocompromised hosts and may therefore not be ideal for other populations. Moreover, the scope of the possible category of IFD has been diminished in the recently revised definitions for classically immunocompromised hosts. Diagnosis of IFD in the ICU presents many challenges, which are different for invasive candidiasis and for invasive aspergillosis. The aim of this article is to review progresses made in recent years and difficulties remaining in the development of definitions applicable in the ICU setting.Entities:
Keywords: biomarker; definition; histology; invasive aspergillosis (IA); invasive candidiasis (IC)
Year: 2021 PMID: 33709127 DOI: 10.1093/cid/ciaa1751
Source DB: PubMed Journal: Clin Infect Dis ISSN: 1058-4838 Impact factor: 9.079